Dry Eye Management in Burbank & Greater Los Angeles

Ask most people what dry eye means and you will hear the same answer: not enough tears. It is the intuitive explanation, and for a minority of patients it is the right one. But it is the wrong starting point for the majority, and starting in the wrong place is the reason so much dry eye care quietly fails.

One reframe changes the entire conversation. Your tears are not simply saltwater. They are a layered film, and the outermost layer is oil (meibum), produced by a row of small glands packed along the rim of each eyelid. That oil is what keeps the watery part of your tears from evaporating between blinks. When those glands clog, thin, or begin secreting poor-quality oil, the film breaks apart in seconds. Your eyes are not short on tears. The tears you have are boiling off too fast. This condition has a name: evaporative dry eye, driven by meibomian gland dysfunction, or MGD.

The distinction is not academic. According to the American Academy of Ophthalmology, MGD is "by far, the principal cause" of evaporative dry eye, which now accounts for up to two-thirds of all cases of dry eye. In published reviews, signs of MGD appear in roughly 70% to 90% of people who have dry eye disease. If you have been fighting dry eye with artificial tears alone and losing, this is very likely why. You have been refilling the tank with the lid off.

The cruel twist: watery eyes are often dry eyes

This one catches patients off guard. Eyes that water, that brim and run in wind or cold, are very often evaporative dry eyes — not the opposite.

The mechanism is simpler than it sounds. When the oily film fails and the surface of the eye dries and stings, the eye reads that irritation as an emergency and floods itself with reflex tears. Those reflex tears are watery and short on oil, so they spill over the lid without ever fixing the dryness underneath. The surface stays irritated, the eye keeps over-producing, and the loop repeats. Tearing and dryness are not opposites here. They are two symptoms of one broken film.

That is also why the symptom list is so scattered, and so easy to wave off. Evaporative dry eye and MGD can show up as any of the following:

• Burning, stinging, or grittiness that worsens as the day goes on.
• Watery, runny eyes, especially outdoors or in wind. This is the reflex-tearing paradox above.
• Blurred vision that clears when you blink and then creeps back a few seconds later, as the tear film breaks up again.
• Tired, heavy eyes after screens, reading, or driving, since we all blink less during focused tasks.
• Crusting, redness, or flaky debris along the lash line, which often signals blepharitis riding alongside the gland dysfunction.

These complaints are common, and they are easy to dismiss as eye strain or simply getting older. They deserve a real look. Among adults over 50, a population-based study found dry eye disease in roughly 11% of people, rising to nearly 23% of women over 75 — and the gland-driven, evaporative form makes up the bulk of it.

It is no longer a condition of getting older

Those figures are drawn from older adults, and Dr. Tuli's view — from the exam chair rather than the literature — is that they now understate the problem. She is seeing dry eye in patients who are far too young for it, and the reason is not mysterious. We spend the day staring at screens, and a focused stare is a stare that does not blink. Blinking is what spreads the oil layer across the eye. Blink less, and the film breaks up faster than it can be rebuilt.

It arrives, in other words, decades earlier than the textbooks would predict, in people who assume their burning, watering, mid-afternoon eyes are simply the price of a job. They are not. They are a treatable gland problem, and the earlier it is caught, the more gland there is left to save.

Dry eye before surgery, not after

There is one more reason to take this seriously, and it is the reason Dr. Tuli is insistent about it: an untreated dry eye will corrupt the measurements taken before lens surgery. The tear film is the first optical surface of the eye. If it is broken and unstable, the readings taken across it are unstable too — and those readings decide which lens power goes into your eye.

So dry eye is diagnosed and treated before a cataract or lens operation here, not discovered afterwards when the vision is disappointing and everyone is looking for an explanation. It is unglamorous, and it is one of the quiet differences between a good result and a frustrating one.

How Dr. Tuli sorts out which dry eye you have

The cornea and the ocular surface are central to a comprehensive ophthalmologist's training, and dry eye is among the conditions Dr. Tuli evaluates most often. Because she is fellowship-trained in cornea and refractive surgery, the front surface of the eye is where her clinical attention naturally lives. That surface is precisely where dry eye does its damage.

A real dry eye evaluation goes well past asking whether your eyes feel dry. Under the microscope, she watches how fast your tear film breaks up after a blink, checks whether your meibomian glands are open and expressing clear oil or blocked and expressing thick, toothpaste-like debris, and looks for the fine surface staining on the cornea that betrays an unhealthy film. She examines the lid margins for blepharitis. She rules out the other conditions that masquerade as dry eye and the ones that quietly drive it. The point is a specific answer to a specific question: aqueous-deficient, evaporative, or the mix of both that most people actually carry. The treatment only makes sense once that answer is in hand.

Treating the cause: a layered, medical approach

Dry eye is managed, not cured, and good management is usually a combination rather than a single fix. The plan gets built to your diagnosis and adjusted as your eyes respond. The measures Dr. Tuli may draw on include:

• Artificial tears and lubricants, matched to your needs. Preservative-free drops for frequent use; thicker gels or ointments at night. These soothe symptoms and buy comfort, but on their own they rarely resolve evaporative dry eye. They treat the puddle, not the plumbing.
• Warm compresses and lid hygiene. Consistent warmth helps soften and release the thickened oil trapped in the meibomian glands, and gentle lid cleaning controls the bacteria and debris that feed blepharitis. Unglamorous, and genuinely effective when done daily.
• Prescription anti-inflammatory therapy. Because chronic dry eye is, at its core, an inflammatory condition, medications that calm that inflammation (such as cyclosporine or lifitegrast, and short, supervised courses of steroid drops in select cases) can help the surface heal and the glands recover. Dr. Tuli weighs whether one fits your situation and monitors you on it.
• Addressing what feeds it. Dry eye rarely arrives alone. Screen habits and a reduced blink rate, contact lens wear, certain medications, rosacea, thyroid and autoimmune conditions, and a dry indoor climate all push it along. Part of the work is finding your contributors and managing them, sometimes alongside your primary doctor.

Most patients improve meaningfully on a thoughtful combination of the above. For some, though, particularly when stubborn gland dysfunction is the engine, drops and compresses only go so far. That is where in-office treatment enters the conversation.

In-office options for stubborn MGD: light and radiofrequency

When evaporative dry eye is driven by meibomian glands that will not stay open, Dr. Tuli may discuss in-office, energy-based treatment as one part of a broader plan. Two technologies are used in our practice for this purpose: intense pulsed light (IPL) and radiofrequency (RF), delivered with the InMode "I" series handpieces: Lumecca-I for IPL and Forma-I for RF.

A point of honesty up front, because the marketing around these devices tends to blur it. These are light- and radiofrequency-based platforms, applied therapeutically to the eyelids and surrounding skin as part of a treatment plan for evaporative dry eye and MGD. That is the accurate way to describe them: a therapeutic use of the technology in the management of gland dysfunction. We are not claiming a procedure that fixes dry eye on its own, and we are careful not to overstate what the devices are formally cleared to do. They are tools inside a plan, not a cure in a single visit.

How they are thought to help, framed as proposed mechanisms rather than guarantees:

• Intense pulsed light (IPL). Pulses of light are applied to the skin along the lower lids and cheeks while the eyes are shielded. Proposed mechanisms include warming and helping to liquefy the hardened oil in the glands, easing the inflammation that drives MGD, and treating the abnormal small blood vessels associated with ocular rosacea that are thought to contribute. IPL is typically performed as a series of sessions spaced a few weeks apart, not a one-time event. Because the response depends partly on skin tone and a few specific conditions, it is not appropriate for everyone.
• Radiofrequency (RF). Controlled radiofrequency energy gently and uniformly warms the lid and the tissue around it. That heat is thought to soften thickened meibum and support better gland expression, and RF is also understood to stimulate collagen and elastin in the treated tissue — one proposed reason it may support the health of the glands themselves beyond simple warming. RF is frequently paired with manual meibomian gland expression, physically clearing the softened, stagnant oil from the glands, so the warmed contents are actually evacuated rather than left to re-harden.

Two things matter more than any device name. First, the honest part about durability. These are management tools, not permanent corrections. When benefit comes, it tends to build over a series of treatments and is generally maintained with periodic sessions and continued home care, not switched on once and forgotten. Second, candidacy is individual. Whether either treatment belongs in your plan is a clinical judgment Dr. Tuli makes after she has examined your glands, your surface, and your skin. It is never a foregone conclusion.